RxDoctor Payments Data

Sanjay Gandhi, MD

Interventional Cardiology · Winston Salem, NCNPI 1295710275

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Edwards Lifesciences at 32.6% of the total. Reporting peaked in 2019 at $1,471 and has fallen 89.9% since, to $148 in 2025. That places this record below the midpoint for interventional cardiology clinicians in NC, where the typical reported total is $5,390.

$4,030in general payments, 2019–2025

Across 44 payments — averaging $91.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1K
  • Boston Scientific$1K
  • Abbott$855
  • Medtronic$517
  • Shockwave Medical, Inc$107
  • Amgen$27
  • plus $36 from 2 others
$161,767in research payments, 2019–2025

Across 48 payments — averaging $3370.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$162K

What the payments were for

  • Travel & lodging$1,84846%
  • Food & beverage$2,17154%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Edwards Lifesciences10$1,314
Boston Scientific11$1,175
Abbott12$855
Medtronic(2 entities)7$517
Shockwave Medical, Inc1$107
Amgen1$27
Abiomed1$24
Chiesi USA, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,030 in reported general payments places this provider in the 35th percentile of 180 interventional cardiology providers in North Carolina.

See all interventional cardiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$66,721
Medicare patients
314
Services billed
513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban163$152,451
EntrestoSacubitril/Valsartan65$70,370
XareltoRivaroxaban46$67,771
Repatha SureclickEvolocumab29$40,107
Ranolazine ErRanolazine50$6,271
Metoprolol Succinate232$2,846
Atorvastatin Calcium135$1,695
Ezetimibe45$1,632
Losartan Potassium118$1,202
Isosorbide Mononitrate ErIsosorbide Mononitrate103$1,034
ClopidogrelClopidogrel Bisulfate103$972
Rosuvastatin Calcium79$864
Carvedilol108$863
Metoprolol Tartrate108$611
Amlodipine Besylate144$606

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →